A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival
Clinical trial NCT00461708 · COMPLETED
Trial details
- NCT number
- NCT00461708
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.